These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 29089464)

  • 1. Correlations of
    Ma SJ; Liu YM; Zhang YL; Chen MW; Cao W
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29089464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between a variable number tandem repeat (VNTR) polymorphism in SMYD3 gene and breast cancer: A genotype-phenotype study.
    Al-Eitan LN; Rababa'h DM
    Gene; 2020 Feb; 728():144281. PubMed ID: 31836525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SET and MYND Domain-Containing Protein 3 (SMYD3) Polymorphism as a Risk Factor for Susceptibility and Poor Prognosis in Ovarian Cancer.
    Liu TT; Xu H; Gao WP; Zhang SX; Zhou XH; Tang J; Liu QN
    Med Sci Monit; 2016 Dec; 22():5131-5140. PubMed ID: 28024138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2 genetic variants affect risk of gastric cancer in the Chinese Han population.
    Zhou Y; Du WD; Wu Q; Liu Y; Chen G; Ruan J; Xu S; Yang F; Zhou FS; Tang XF; Tang HY; Zuo XB; Zhang FY; Sun LD; Zhang XJ
    Mol Carcinog; 2014 Aug; 53(8):589-97. PubMed ID: 22228224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SMYD3 VNTR 3/3 polymorphism confers an increased risk and poor prognosis of hepatocellular carcinoma in a Chinese population.
    Li RD; Tang YH; Wang HL; Yang D; Sun LJ; Li W
    Pathol Res Pract; 2018 May; 214(5):625-630. PubMed ID: 29691085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
    Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
    Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
    Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
    Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
    Liu Y; Liu H; Luo X; Deng J; Pan Y; Liang H
    Tumour Biol; 2015 Jun; 36(6):4377-86. PubMed ID: 25627005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMYD3 regulates gastric cancer progression and macrophage polarization through EZH2 methylation.
    Wang P; Zhao L; Rui Y; Ding Y
    Cancer Gene Ther; 2023 Apr; 30(4):575-581. PubMed ID: 36127410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Enhancer of Zeste 2 (EZH2) Genotypes with Bladder Cancer Risk in Taiwan.
    Chang WS; Liao CH; Tsai CW; Hu PS; Wu HC; Hsu SW; Hsiao CL; Hsu CH; Hung YW; Bau DT
    Anticancer Res; 2016 Sep; 36(9):4509-14. PubMed ID: 27630289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma.
    Binh MT; Hoan NX; Giang DP; Tong HV; Bock CT; Wedemeyer H; Toan NL; Bang MH; Kremsner PG; Meyer CG; Song LH; Velavan TP
    Sci Rep; 2020 Feb; 10(1):2797. PubMed ID: 32071406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumours.
    Sponziello M; Durante C; Boichard A; Dima M; Puppin C; Verrienti A; Tamburrano G; Di Rocco G; Redler A; Lacroix L; Bidart JM; Schlumberger M; Damante G; Russo D; Filetti S
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):8-13. PubMed ID: 24813658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Levels of SET and MYND Domain-Containing Protein 3 Are Correlated with Overexpression of Transforming Growth Factor-β1 in Gastric Cancer.
    Liu H; Liu Y; Kong F; Xin W; Li X; Liang H; Jia Y
    J Am Coll Surg; 2015 Aug; 221(2):579-90. PubMed ID: 26077602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
    Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
    Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions.
    Inari H; Suganuma N; Kawachi K; Yoshida T; Yamanaka T; Nakamura Y; Yoshihara M; Nakayama H; Yamanaka A; Masudo K; Oshima T; Yokose T; Rino Y; Shimizu S; Miyagi Y; Masuda M
    BMC Cancer; 2017 Feb; 17(1):160. PubMed ID: 28241804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer.
    Lobo J; Rodrigues Â; Antunes L; Graça I; Ramalho-Carvalho J; Vieira FQ; Martins AT; Oliveira J; Jerónimo C; Henrique R
    Urol Oncol; 2018 Apr; 36(4):161.e7-161.e17. PubMed ID: 29174711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R; Har YC; Taib NA
    J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study.
    Bayram S; Sümbül AT; Dadaş E
    Tumour Biol; 2016 Apr; 37(4):5577-84. PubMed ID: 26577852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility.
    Lee SW; Park DY; Kim MY; Kang C
    Gastric Cancer; 2019 May; 22(3):640-644. PubMed ID: 30374835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MMP-2 -735 C allele is a risk factor for susceptibility to breast cancer.
    Yari K; Rahimi Z; Moradi MT; Rahimi Z
    Asian Pac J Cancer Prev; 2014; 15(15):6199-203. PubMed ID: 25124598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.